BMO Capital Initiates Coverage On Zimmer Biomet Holdings with Market Perform Rating, Announces Price Target of $95

Benzinga Newsdesk www.benzinga.com Positive 59.3%

Neg 0% Neu 0% Pos 59.3%

BMO Capital analyst Vik Chopra initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform rating and announces Price Target of $95.